Webinar on

Breast Cancer & Blood Cancer

Breastcancer-2020

Theme: Exploring Advanced Therapeutics for Breast and Blood cancer

Breast Cancer 2020, which is going to be held during October 19-20, 2020, at London, UK (Time Zone) Will be emphasized on the theme “Exploring Advanced Therapeutics for Breast and Blood cancer”. Breast Cancer 2020 will serve an excellent experience and opportunities to enhance one's career. Join our webinar to exchange various Innovative approaches in Breast Cancer and Blood cancer. This webinar will be an inestimable and important platform for motivating international and integrative exchange at the forefront of Breast Cancer and Blood cancer. Over the course of 2 days, internationally-renowned speakers will exemplify how their research exploration has developed in response to present day challenges. The attending professionals and industry associates will also provide   exotic networking experience.The webinar will assemble together Oncologist, Surgeons, Radiologist, Haematologists, Pathologists, Immunologists Chemotherapists, Gynaecologists, academicians from all over the world.

 

Session 1: Breast Cancer Therapy, Prevention and Medicine

Breast cancer is treated in several ways. It depends on the kind of breast cancer and how far it has spread. People with breast cancer often get more than one kind of treatment. Surgery. An operation where doctors cut out cancer tissue. Chemotherapy: Using special medicines to shrink or kill the cancer cells. The drugs can be pills you take or medicines given in your veins, or sometimes both. Hormonal therapy: Blocks cancer cells from getting the hormones they need to grow. Biological therapy: Works with your body’s immune system to help it fight cancer cells or to control side effects from other cancer treatments. Radiation therapy: Using high-energy rays (similar to X-rays) to kill the cancer cells.

Session 2: Treatment for Breast Cancer: Advanced Detection & Therapies‎

Cancer is a broad term for a class of diseases characterized by abnormal cells that grow and invade healthy cells in the body. Breast cancer starts in the cells of the breast as a group of cancer cells that can then invade surrounding tissues or spread (metastasize) to other areas of the body. Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of death among women. Early diagnosis of the disease plays a vital role in the treatment and outcomes of breast cancer. Screening for breast cancer is very important for early diagnosis.

  • Surgery for Breast Cancer
  • Radiation for Breast Cancer
  • Chemotherapy for Breast Cancer
  • Hormone Therapy for Breast Cancer
  • Targeted Therapy for Breast Cancer
  • Immunotherapy for Breast Cancer
  • Treatment of Breast Cancer by Stage
  • Treatment of Triple-negative Breast Cancer
  • Treatment of Inflammatory Breast Cancer
  • Treating Breast Cancer During Pregnancy

Session 3: Breast Cancer Stages & Types of Surgery

Indications of breast cancer are the similar in men like women. Maximum of the men are not aware of this and the treatment of breast cancer males is mostly tardy as compared to females because of obliviousness. Major risk features of breast cancer that occur are during the premenopausal years, the rate of upsurge in occurrence is common everywhere in the world, roughly about 8%-9% per year, breastfeeding each kid for less than 6 months, and physical idleness, are each related to an predictable 3% of female breast cancer cases. Lifestyle factors including overweight and obesity, alcohol and certain work-related exposures also lead to breast cancer. There are many forms of cancer treatment. The types of treatment that you take depends on the nature of cancer you have and its severity. Some people with cancer will undergo only one treatment procedure. But most people have a blend of treatments, such as surgery with chemotherapy and/or radiation therapy. There are certain effective modes like immunotherapy, targeted therapy, or hormone therapy conducive for certain type of cancer

  • Breast Cancer Surgery
  • Radiation Therapy & Chemotherapy
  • Immunotherapy to Treat Cancer
  • Targeted Therapy & Hormone Therapy
  • Stem Cell Transplant
  • Precision Medicine

Session 4: Cancer and Tumour Immunology

Cancer immunology shows the relationship between the immune system and the progression of cancer. The Basic mechanism of the immune system as it relates to cancer has been increasing rapidly. Although there is ample evidence for anti-tumour immune reactivity in humans, evidence for immunity against malignancy comes mostly from experimental studies with animals to prevent the progression of neoplastic tissue, the immune system identifies the transformed cells which is called Cancer immune surveillance. According to the Immune Surveillance Theory, cancer cells that arise in the body are eliminated by the immune system. However, due to impaired immune reactivity, cancer cells may escape destruction. This particular scientific session of the Breast Cancer Conference shall highlight immune therapy related to tumours.

Session 5: Advanced Technology: 3-D Mammography & Cyberknife

The most sensitive test to detect breast cancer. 3D mammography is a screening and diagnostic breast imaging tool to improve the early detection of breast cancer. During the exam, an x-ray arm sweeps over the breast, taking multiple images in seconds. Images are displayed as a series of thin slices that can be viewed by our radiologists as individual images or in a dynamic interactive animation. Cyberknife is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body.The treatment delivers beams of high dose radiation to tumors with extreme accuracy. Cyber Knife VSI is the world's only whole body radiosurgery system with unmatched accuracy and precision.

Session 6: Breast Cancer and Cell Biology

Cancer cells are very complex cells and it is challenging for clinicians to manage breast cancer therapy. Tumor cells are having different phenotypes and deregulated apoptotic and these characteristics are responsible for improper therapeutic response. For multidrug resistance events major role is played by membrane transporters, they are the cell’s first line of contact with anticancer drugs. So cell structure and biological properties of the cell leads to drug-resistant and lead to a decrease in the intracellular activity of drugs. Breast growth is regulated by the interaction between hormones and growth factors. Genetic changes in growth factor can lead to abnormalities. The immune system of host play a substantial role during breast cancer, breast cancer is a complex disease.

Session 7: Breast Cancer Pathophysiology

There are trillions of cells in the body. These cells have a tightly regulated cell cycle that controls their growth, maturity, division and death. During childhood normal cells divide faster to allow the person to grow. Once adulthood is reached the cells divide to replace worn-out cells and to repair injuries. This cell division and growth is controlled by the cellular blue print or DNA and genes that lie within the cell’s nucleus. Cancer begins when cells in a part of the body start to grow out of control. All types of cancer, irrespective of their origin, occur due to this disturbed growth of cells that leads to formation of tumours and lesions. In addition, the cancer cells possess some rogue like properties: They have longer life spans and instead of dying continue to grow and form new, abnormal cells Cancer cells can also invade other tissues. This is something that normal cells cannot do. This property is called metastasis. Cancer cells grow into tumours that are supplied by a new network of blood vessels. This is called angiogenesis and is unique in maintaining the blood supply and supply of nutrients to the cancer cells.

Session 8: Mammography

Mammography is specialized medical imaging that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women. An x-ray (radiograph) is a non-invasive medical test that helps physicians diagnose and treat medical conditions. Imaging with x-rays involves exposing a part of the body to a small dose of ionizing radiation to produce pictures of the inside of the body. X-rays are the oldest and most frequently used form of medical imaging. Three recent advances in mammography include digital mammography, computer-aided detection and breast tom synthesis. Digital mammography, also called full-field digital mammography (FFDM), is a mammography system in which the x-ray film is replaced by electronics that convert x-rays into mammographic pictures of the breast. These systems are similar to those found in digital cameras and their efficiency enables better pictures with a lower radiation dose. These images of the breast are transferred to a computer for review by the radiologist and for long term storage. The patient's experience during a digital mammogram is similar to having a conventional film mammogram. Computer-aided detection (CAD) systems search digitized mammographic images for abnormal areas of density, mass, or calcification that may indicate the presence of cancer. The CAD system highlights these areas on the images, alerting the radiologist to carefully assess this area.

Session 9: Blood Cancers & Types of Blood Cancers

Most blood cancers, also called hematologic cancers, start in the bone marrow, which is where blood is produced. Blood cancers occur when abnormal blood cells start growing out of control, interrupting the function of normal blood cells, which fight off infection and produce new blood cells. The three main types of blood cancer are leukaemia, lymphoma and myeloma: Leukaemia is a blood cancer that originates in the blood and bone marrow. It occurs when the body creates too many abnormal white blood cells and interferes with the bone marrow’s ability to make red blood cells and platelets. Non-Hodgkin lymphoma is a blood cancer that develops in the lymphatic system from cells called lymphocytes, a type of white blood cell that helps the body fight infections. Hodgkin lymphoma is a blood cancer that develops in the lymphatic system from cells called lymphocytes. Hodgkin lymphoma is characterized by the presence of an abnormal lymphocyte called the Reed-Sternberg cell. Multiple myeloma is a blood cancer that begins in the blood’s plasma cells, a type of white blood cell made in the bone marrow.

Session 10: Blood cancer treatment and therapy

Treatment for blood cancer depends on the type of cancer, your age, how fast the cancer is progressing, where the cancer has spread and other factors. Some common blood cancer treatments include: Stem cell transplantation: A stem cell transplant infuses healthy blood-forming stem cells into the body. Stem cells may be collected from the bone marrow, circulating blood and umbilical cord blood. Chemotherapy: Chemotherapy uses anticancer drugs to interfere with and stop the growth of cancer cells in the body. Chemotherapy for blood cancer sometimes involves giving several drugs together in a set regimen. This treatment may also be given before a stem cell transplant. Radiation therapy: Radiation therapy may be used to destroy cancer cells or to relieve pain or discomfort. It may also be given before a stem cell transplant.

Session 11: Blood Cancer Diagnosis and Staging

Blood cancers affect the production and function of your blood cells. Most of these cancers start in your bone marrow where blood is produced. Stem cells in your bone marrow mature and develop into three types of blood cells: red blood cells, white blood cells, or platelets. In most blood cancers, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent your blood from performing many of its functions, like fighting off infections or preventing serious bleeding. There are three main types of blood cancers: Leukaemia, a type of cancer found in your blood and bone marrow, is caused by the rapid production of abnormal white blood cells. The high number of abnormal white blood cells are not able to fight infection, and they impair the ability of the bone marrow to produce red blood cells and platelets. Lymphoma is a type of blood cancer that affects the lymphatic system, which removes excess fluids from your body and produces immune cells. Lymphocytes are a type of white blood cell that fight infection. Abnormal lymphocytes become lymphoma cells, which multiply and collect in your lymph nodes and other tissues. Over time, these cancerous cells impair your immune system. Myeloma is a cancer of the plasma cells. Plasma cells are white blood cells that produce disease- and infection-fighting antibodies in your body. Myeloma cells prevent the normal production of antibodies, leaving your body's immune system weakened and susceptible to infection.

Session 12: Blood Cancer-Hematology

Blood cancer is a type of cancer that affects your blood cells. It starts in your bone marrow where blood cells form. Blood cancer affects the blood cells by not allowing them to function properly. This leads to issues like not being able to fight off germs that cause sickness or stop bleeding when you get a cut. There are three different types of cells in your blood: red blood cells, white blood cells and platelets. Blood cancer can affect any of these cells. Leukemia: This cancer causes white blood cells to produce rapidly and abnormally. These cells can't fight off infections, and they also prevent red blood cells and platelets from doing their jobs. Lymphoma: This cancer affects the part of the body that removes excess fluids and produces healthy white blood cells in the body. It turns normal white blood cells that fight infection — called lymphocytes — into abnormal lymphoma cells. They build up in your lymph nodes and affect your body's ability to fight off sickness. Myeloma: This cancer affects the plasma cells. Plasma is responsible for producing antibodies to fight off infections. Myeloma prevents this from happening, leaving you with a weakened immune system.

Market Analysis:

Cancer is the second leading cause of death worldwide. Its crucial to remember that cancer is not one disease, its more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers dont work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer (or) oncology.

The global breast cancer drugs market size was valued at USD 16.98 billion in 2018 and is expected to register at a CAGR of 10.7% over the forecast period. Rising prevalence of the disease along with emerging novel therapies are some of the major factors likely to drive the market. Early detection of breast cancer is a key to effective management of the disease.

Breast cancer in Middle East:

The impression among Arab Physicians handling breast cancer is that it presents at associate earlier age and at an additional advanced stage as compared to western countries. However, the applied math information to support this impression is remarkably scarce. Breast cancer incidence varied wide among the four collaborating countries, with the very best rates in human Israeli ladies (100.4/100,000) and therefore the lowest rates in Turkish ladies (50.7/100,000). In place carcinoma were significantly higher within the SEER population than within the MECC written account population.

Breast cancer biology in USA & Canada:

In the year twenty17 nearly thirteen of all cancers diagnosed in adults ages 20 and older are rare cancers, during this report as a cancer with fewer than vi cases per 100,000 individuals each year. This year’s special section reviews statistics for twenty eight rare cancers, together with incidence and mortality rates and trends, stage at identification, and survival, and additionally provides a summary of risk factors and symptoms for choose cancers. it's supposed to tell anyone concerning| inquisitive about| fascinated by} learning additional about rare cancers in adults, together with policy manufacturers, researchers, clinicians, cancer management advocates, patients, and caregivers.

Breast cancer biology in UK & Europe:

Breast cancer is that the most typical variety of cancer within the United Kingdom & Europe, however survival over the last forty years has nearly doubled. Today, eight in ten ladies diagnosed with breast cancer can survive their wellness for ten years or additional. In United Kingdom breast cancer Care survey found one in four ladies (26%) notice the tip of treatment the toughest a part of breast cancer and only 1 in ten (10%) say they felt positive and prepared to maneuverer on once they were discharged from hospital treatment. over [*fr1] (53%) struggled with anxiety at the tip of treatment and nearly a 3rd (31%) with depression.

Breast in Asia-Pacific:

Breast cancer is that the commonest cancer in most countries in Asia. The incidence rates stay low, though increasing at a lot of fast rate than in western countries, as a result of changes within the fashion and diet. Asia compared with western countries several variations between breast cancers. The mean age at onset is younger than within the west, and in contrast to the west, the age-specific incidence decreases once the age of fifty years. as a result of there's no population-based carcinoma screening program within the majority of Asian countries, the bulk of patients present with advanced illness .In Asia pacific there's a better proportion of endocrine receptor-negative patients.

Top Universities around the World:

Georg-August University, Gottingen, Germany
National Center for Tumor Diseases (NCT), Dresden, Germany
Breast Center, Holweide Hospital, Cologne, Germany.
National Center for Tumor Diseases (NCT) Heidelberg
Charité Comprehensive Cancer Center
Breast Cancer Research Centre, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany
International Agency for Research on Cancer, Lyon, France
National Cancer Institute, Cairo University, Cairo, Egypt
National Cancer Institute, Bethesda, MD, USA
Haceteppe University Institute of Oncology, Ankara, Turkey
Israel Cancer Association
National University of Singapore
Hong Kong University of Science & Technology
Peking University
The Chinese University of Hong Kong
University of Hong Kong

Top Societies and Association around the World:

American Cancer Society
American Society for Radiation Oncology
American Society of Paediatric Haematology/Oncology
Association of Cancer Physicians
Cancer Relief Society Nepal
Cancer Society of Finland
Cancer Society of New Zealand
Breast Screen Australia Program
Indonesian Society of Gynecologic Oncology
International Gynecologic Cancer Society
Iranian Society of Radiation Oncology
Japanese Breast Cancer Society
Thai Gynecologic Cancer Society
Spanish Oncology Nursing Society
Kuwait Cancer Control Centre
Hayatt Foundation Kuwait
National Cancer Institute
International Agency for Research on Cancer, Lyon, France
National Cancer Institute, Cairo University, Cairo, Egypt
National Cancer Institute, Bethesda, MD, USA
Haceteppe University Institute of Oncology, Ankara, Turkey
Israel Cancer Association
National University of Singapore

References

https://www.grandviewresearch.com/industry-analysis/breast-cancer-drugs-market
https://www.cancer.gov/types/breast/research
https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-015-0184-3
https://www.medicalnewstoday.com/articles/37136.php

Young Scientist Awards at Neuroscience 2020 for the best researches in Neuroscience

Meetings International is announcing Young Scientist Awards through Webinar on Neuroscience (Neuroscience 2020) which is scheduled on November 19, 2020. This Neuroscience 2020 webinar focuses on Breakthroughs and Achievements in Neurocognitive Research

Neuroscience 2020 and upcoming webinar will recognise participants who have significantly added value to the scientific community of Medical science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Neuroscience Webinar.


 

Global Summit on Breast Cancer & Blood Cancer  will serve excellent experience and opportunities to enhance one's career. Join us in London to exchange various Innovative approaches in Breast Cancer and Blood cancer. Breast Cancer 2020 organizing committee anticipates over 300 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Oncology. Breast Cancer 2020 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Meetings Int. receives 400,000+ online visitors with 1000+ sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally.  Advertise on a platform where all of our conferences are listed to target a large audience of people. Here is your chance to publicize in the site that can interface you to driving specialists and science pros over the Globe.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world.

Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at breastcancer@insightsummits.com; sponsor@meetingsint.com

You can also connect us via WhatsApp: +65 3158 1626 / + 44 122980269

Google Analytics Metrics of Breast Cancer 2020:

  • The visitor’s traffic is the benchmark for the success of conference and Breast Cancer 2020 is constantly attracting viewers across the world.
  • According to the Google Analytics, more than 700+ monthly audiences are visiting to our conference websites for submitting abstracts, brochure downloads, registration, exhibition and sponsorship queries.
  • Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

  • 437,380 + Users
  • 1,606,987 + Page views
  • 644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.

 

  • Breast Cancer Therapy, Prevention and Medicine
  • Treatment for Breast Cancer: Advanced Detection & Therapies
  • Breast Cancer Stages & Types of Surgery
  • Cancer and Tumour Immunology
  • Advanced Technology: 3-D Mammography & Cyberknife
  • Breast Cancer and Cell Biology
  • Breast Cancer Pathophysiology
  • Mammography
  • Blood Cancers & Types of Blood Cancers
  • Blood Cancer treatment and therapy
  • Blood Cancer Diagnosis and Staging
  • Blood Cancer-Hematology